According to a report by Cosmetic­sBridge, in preparation for the implemen­tation of China’s long-awaited Cosmetics Supervision and Administ­ration Regulations (CSAR), The National Medical Products Administ­ration (NMPA) has issued standards for product safety and efficacy testing and claims.

According to the source, both the “Cosmetics Efficacy Claim Evaluation Standards” and “The Technical Guidelines for Cosmetic Safety Assessment (2021 Edition)” will go into effect on May 1, 2021.

Those applying for either special or general cosmetics must evaluate product claims under the requirements set forth under the given “Specifi­cation” (see below) and provide a summary of the basis for product efficacy claims via a website designated by the NMPA.

In relation, cosmetic safety assessments must be conducted in accordance with the requirements of the “Technical Guidelines” (see below) before applying for either special cosmetics registration or general cosmetics notification; product safety assessment materials also must be submitted.

Read more…

Published by Rachel Grabenhofer on April 9, 2021